←
ixlayer214 posts
ixlayer avatar

ixlayer

@ixlayer_

ixlayer is the only end-to-end, direct-to-patient platform built for biopharma and optimized for patient choice.

◷ Joined December 2019▧ 50 Photos and videos
ixlayer avatar
ixlayer@ixlayer_·2 Apr 2025

Almost every pharma marketer and commercialization leader is asking about direct-to-patient platform opportunities. But what do patients want? Thanks to @FiercePharma and the reporting by @andreapark on the ixlayer #ixInsight2025 Study with @Ipsos. fiercepharma.com/marketing/p…

ixlayer avatar
ixlayer@ixlayer_·7 Feb 2025

We are excited to be named to the @DigitalHealthNY 100, joining the ranks of past winners @capsule_health , @mavenclinic , @OscarHealth, @ro , @swordhq , @Talkiatry , @talkspace and @Zocdoc. Read more in today's press release: ixlayer.com/2025/02/06/ixlay…

Pear VC avatar
⟳ ixlayer retweeted
Pear VC@pearvc·23 Oct 2024

We're so proud to share that ixlayer has announced their Complete Blood Count test with their direct-to-patient biopharma programs through ixEngage. ixLayer is paving the future for at-home testing access for patients. Congratulations! #HLTHUSA

ixlayer@ixlayer_22 Oct 2024

Today at #HLTHUSA, we announced the availability of a Complete Blood Count (CBC) test with at-home sample collection for direct-to-patient (DTP) biopharma programs. Routine CBC tests is used for asthma, heart disease, and kidney disease. #HLTHUSA2024 #hlth ixlayer.com/complete-blood-c…

Pejman Nozad avatar
⟳ ixlayer retweeted
Pejman Nozad@pejmannozad·23 Oct 2024

We're so proud to share that ixlayer has announced their Complete Blood Count test with their direct-to-patient biopharma programs through ixEngage. ixLayer is paving the future for at-home testing access for patients. Congratulations! #HLTHUSA

ixlayer@ixlayer_22 Oct 2024

Today at #HLTHUSA, we announced the availability of a Complete Blood Count (CBC) test with at-home sample collection for direct-to-patient (DTP) biopharma programs. Routine CBC tests is used for asthma, heart disease, and kidney disease. #HLTHUSA2024 #hlth ixlayer.com/complete-blood-c…

ixlayer avatar
ixlayer@ixlayer_·11 Sep 2024

We’re pleased to announce the launch of ixEngage, our direct-to-patient solution for biopharma that builds on our groundbreaking digital platform that has powered 1,110+ nationwide programs and over 4 million patient care journeys: prnewswire.com/news-releases…

ixlayer avatar
ixlayer@ixlayer_·29 Jul 2024

ixlayer direct-to-patient platform allows biopharma organizations to quickly launch an optimized patient Cx with transparency and control. Our configurable platform enables us to build distinct programs for multiple therapeutic areas within biopharma ecosystem.

1:07
ixlayer avatar
ixlayer@ixlayer_·25 Jun 2024

Doctors support growth of at-home testing, survey finds, opening new avenues for biopharma patient outreach fiercepharma.com/marketing/d…